EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: implications for anti-EGFR treatment of a rare lung malignancy.
about
Epidemiological features of lung giant cell carcinoma and therapy for patients with EGFR mutations based on case reports and the surveillance, epidemiology, and end results (SEER) database.Clinical Significance and Next-Generation Sequencing of Chinese Pulmonary Sarcomatoid Carcinoma.sZIP, an alternative splice variant of ZIP, antagonizes transcription repression and growth inhibition by ZIPSarcomatoid carcinoma of the lung: a model of resistance of chemotherapy.Clinicopathologic outcomes of curative resection for sarcomatoid carcinoma of the lung.Molecular profiles of EGFR, K-ras, c-met, and FGFR in pulmonary pleomorphic carcinoma, a rare lung malignancyEpithelial-mesenchymal transition in pulmonary carcinosarcoma: case report and literature review.Epidermal growth factor receptor mutation heterogeneity analysis of pulmonary sarcomatoid carcinoma successfully treated with erlotinib: A case reportSarcomatous Carcinoma of the Orbit: A Case Report and Review of the LiteratureEGFR and KRAS mutations in pulmonary pleomorphic carcinoma and their correlation with clinicopathologic featuresPrimary adrenal sarcomatoid carcinoma metastatic to the lung: Case report and review of the literature.Small bowel intussusception due to metastatic intestinal carcinosarcoma from a pulmonary primaryPulmonary sarcomatoid carcinoma: a case report.KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma.Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases.Sarcomatoid carcinoma of lung - A case report and review of epidermal growth factor receptor mutation status.Pulmonary Sarcomatoid Carcinoma with ALK Rearrangement: Frequency, Clinical-Pathologic Characteristics, and Response to ALK Inhibitor.Upper lip metastasis of sarcomatoid carcinoma of the lung - an unusual site of disease: a case reportHistopathologic and molecular approach to staging of multiple lung nodules.Case series of pleomorphic carcinomas of the lung treated with nivolumab.Recent advances in the management of pulmonary sarcomatoid carcinoma.[NP protocol taken for pulmonary sarcomatoid carcinoma: a case report].High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets.
P2860
Q33648864-45BE0A4C-4E2D-4F7F-8BBA-F6DD4CC5F8B4Q33822393-F073252D-7939-4C7C-B710-DA8E8726BFFBQ33825091-56508532-D27A-4178-A87C-7416113141E3Q33964619-7D496B4E-F880-4C28-B362-9B1992E3088CQ34231841-0BD7CAEA-3105-4F0E-A39F-694C5592EF69Q35097581-1670BDF1-C76B-422E-958C-FFDC01D59F93Q35628116-B6E0110C-4AC2-4E51-9122-9689B49C9BB6Q35742314-CD536383-92F4-462D-B383-C8DAA14DE8BDQ35773149-8B15957B-9E33-4E97-BB5E-859B529AE442Q35867291-7DB110A2-B8B9-4B12-B9FC-287F37E80BDBQ36826032-F06796A8-2F63-4869-88FC-6D6E948442DCQ36856552-82662AFB-E79D-4DCB-99EF-C895B76C8E64Q36936799-F7F5DF19-2B2F-44F2-A1C9-D304BBFE7CB5Q37067360-AF53A22C-D880-42AA-8BF0-D88BAE4178C6Q37363842-CB4B16B1-034E-4AFF-8FE8-2A5841115C29Q38656377-3CD4C487-92A5-45D7-8F38-639CDDBEE777Q41211243-CF64B1B1-DD4A-4776-869C-0D9F81F18CB8Q42014893-0616CD46-8EFE-456B-B902-30491BAA723DQ47144893-59A5502C-6D8E-4BD6-8F4D-1D469126DD02Q47148618-C32B53B2-A8B1-43F6-9BCF-C5EDC5AC4373Q52881354-43CA9464-723E-45A6-896E-6D4B4D100C77Q53220799-781D6236-CAF1-482F-AA51-01D570A09EBAQ53843394-4E8EFE85-0AC8-462B-8C47-B268111C1902
P2860
EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: implications for anti-EGFR treatment of a rare lung malignancy.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
EGFR and KRAS status of primar ...... ent of a rare lung malignancy.
@ast
EGFR and KRAS status of primar ...... ent of a rare lung malignancy.
@en
EGFR and KRAS status of primar ...... ent of a rare lung malignancy.
@nl
type
label
EGFR and KRAS status of primar ...... ent of a rare lung malignancy.
@ast
EGFR and KRAS status of primar ...... ent of a rare lung malignancy.
@en
EGFR and KRAS status of primar ...... ent of a rare lung malignancy.
@nl
prefLabel
EGFR and KRAS status of primar ...... ent of a rare lung malignancy.
@ast
EGFR and KRAS status of primar ...... ent of a rare lung malignancy.
@en
EGFR and KRAS status of primar ...... ent of a rare lung malignancy.
@nl
P2093
P50
P356
P1476
EGFR and KRAS status of primar ...... ment of a rare lung malignancy
@en
P2093
Antoine Italiano
Daniel Pop
Florence Pedeutour
Ghyslaine Martel-Planche
Paul Hofman
Thibault Fabas
Veronique Hofman
P304
P356
10.1002/IJC.24610
P577
2009-11-01T00:00:00Z